Genpact Q3 revenue rises 6.6% to $1.291 billion; raises 2025 EPS outlook
Genpact reported third-quarter 2025 results for the period ended September 30, with net revenues of $1.291 billion, up 6.6% year-over-year, and adjusted diluted EPS of $0.97, up 14.1%. The company raised its full-year 2025 adjusted diluted EPS guidance to $3.60 to $3.61, from $3.51 to $3.58, and raised its full-year net revenue growth outlook to 6.1% to 6.4% as reported.
Key points
- Q3 net revenues were $1.291 billion, up 6.6%; Advanced Technology Solutions revenues rose 20.0% to $311 million
- GAAP diluted EPS was $0.83, up 12.2%; net income was $146 million, up 9.8%
- Full-year 2025 adjusted diluted EPS guidance raised to $3.60 to $3.61 from $3.51 to $3.58
- Q4 2025 adjusted diluted EPS guidance is $0.93 to $0.94; the company repurchased about 2.0 million shares for about $90 million in the quarter
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 06, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.